OS Therapies Statistics Share Statistics OS Therapies has 31.62M
shares outstanding. The number of shares has increased by 34.54%
in one year.
Shares Outstanding 31.62M Shares Change (YoY) 34.54% Shares Change (QoQ) 29.09% Owned by Institutions (%) n/a Shares Floating 17.78M Failed to Deliver (FTD) Shares 59,255 FTD / Avg. Volume 11.79%
Short Selling Information The latest short interest is 524.9K, so 1.54% of the outstanding
shares have been sold short.
Short Interest 524.9K Short % of Shares Out 1.54% Short % of Float 1.88% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.01 and the forward
PE ratio is -12.43.
OS Therapies's PEG ratio is
0.
PE Ratio -0.01 Forward PE -12.43 PS Ratio 0 Forward PS 2.7 PB Ratio 0.01 P/FCF Ratio -12.27 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OS Therapies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.2,
with a Debt / Equity ratio of 0.
Current Ratio 1.2 Quick Ratio 1.2 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.22B Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -53.74% in the
last 52 weeks. The beta is -4.14, so OS Therapies's
price volatility has been lower than the market average.
Beta -4.14 52-Week Price Change -53.74% 50-Day Moving Average 1.75 200-Day Moving Average 2.19 Relative Strength Index (RSI) 48.61 Average Volume (20 Days) 502,607
Income Statement
Revenue n/a Gross Profit n/a Operating Income -6.81B Net Income -8.88B EBITDA -6.81B EBIT -10.93B Earnings Per Share (EPS) -71.77
Full Income Statement Balance Sheet The company has 5.53M in cash and 0 in
debt, giving a net cash position of 5.53M.
Cash & Cash Equivalents 5.53M Total Debt n/a Net Cash n/a Retained Earnings -40.4B Total Assets 4.25M Working Capital 559.09K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.28M
and capital expenditures 0, giving a free cash flow of -7.28M.
Operating Cash Flow -7.28M Capital Expenditures n/a Free Cash Flow -7.28M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
